Skip to main content

Table 3 Correlations between osteoprotegerin and clinical and biochemical characteristics, and cardiac dimensions, function, and myocardial metabolism

From: Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men

 

Pooled analysis

T2DM

Controls

Age (years)

0.217*

0.343*

-0.354

BMI (kg/m2)

0.054

0.050

-0.180

Systolic blood pressure (mmHg)

0.232*

0.181

0.297

Diastolic blood pressure (mmHg)

0.194

0.180

0.192

HbA1c (%)

0.325*

0.249*

0.312

Rate pressure product ((beats/min)mmHg)

0.200

0.114

0.319

Log distensibility aorta ascendens (10-3mm Hg-1)

-0.401*

-0.327*

-0.623*

LV mass (g)

0.034

0.096

-0.180

LV mass/volume ratio (g/mL)

0.277*

0.311*

-0.164

Log LV enddiastolic volume (mL)

-0.213*

-0.211

-0.044

Log LV endsystolic volume (mL)

-0.269*

-0.248*

-0.116

LV ejection fraction (%)

0.199

0.161

0.343

E peak filling rate (mL/s)

-0.190

-0.193

-0.022

Log E deceleration peak (mL/s210-3)

-0.167

-0.156

-0.083

E/A peak ratio

-0.223*

-0.272*

-0.095

MMRglu (nmol/mL/min)

-0.308*

-0.307*

-0.055

  1. Data are Pearson's r. BMI: body mass index; HbA1c: glycated hemoglobin; LV: left ventricular; E/A: ratio of peak filling rates of the early filling phase and arterial contraction; MMRglu: myocardial metabolic rate of glucose uptake.
  2. * P < 0.05.